Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Questiomycin B SCHEMBL11671248 | 1.00 | ALOX15 (0.65) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Questiomycin B SCHEMBL2411821 | 0.94 | ALOX15 (0.58) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Questiomycin B SCHEMBL8718526 | 0.86 | ALOX15 (0.79) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Questiomycin B SCHEMBL10786495 | 0.84 | ALOX15 (0.75) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Questiomycin B SCHEMBL27305569 | 0.84 | ALOX15 (0.75) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Catechol SCHEMBL5431374 | 0.84 | CA2 (0.56) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Ether SCHEMBL28632893 | 0.84 | ALDH1A1 (0.56) | ALOX15TSHRALDH1A1HSD17B10CYP1A2 | |
| Catechol SCHEMBL27085 | 0.84 | CA2 (0.56) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Ether SCHEMBL6065896 | 0.83 | TSHR (0.43) | ALOX15TSHRALDH1A1HSD17B10CA2 | |
| Questiomycin B SCHEMBL27521296 | 0.81 | ALOX15 (0.88) | ALOX15TSHRALDH1A1HSD17B10CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111171246-A | Amphoteric polycarboxylic acid water reducing agent and preparation method thereof | 马清浩 | 2020-05-19 | — | — | CN | claimed |
| EP-2961739-A2 | FURFURAL DERIVATIVES AS A VEHICLE | Rhodia Operations (FR) | 2016-01-06 | — | — | EP | claimed |
| WO-2014132178-A2 | FURFURAL DERIVATIVES AS A VEHICLE | RHODIA OPERATIONS (FR) | 2014-09-04 | — | — | WO | claimed |
| US-20080171765-A1 | Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents | ACADEMIA SINICA (TW) | 2008-07-17 | — | — | US | claimed |
| US-4231963-A | ETHERIFICATION OF ALKALI METAL AMINOPHENOLATE | IHARA CHEMICAL INDUSTRY COMPANY, LIMITED (JP) | 1980-11-04 | — | — | US | claimed |
| US-4125717-A | NITROSATION OF AMINOPHENOL ETHERS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | claimed |
| JP-55062052-A | — | — | None | — | — | JP | disclosed |
| JP-55057542-A | — | — | None | — | — | JP | disclosed |
| JP-55057542-A | — | — | None | — | — | JP | disclosed |
| JP-55062053-A | — | — | None | — | — | JP | disclosed |
| JP-55062053-A | — | — | None | — | — | JP | disclosed |
| JP-2000244-A | — | — | None | — | — | JP | disclosed |
| JP-2000244-A | — | — | None | — | — | JP | disclosed |
| JP-S5557542-A | PREPARATION OF AMINOPHENOL ETHER | NIPPON TOKUSHU KAGAKU KOGYO KK | 1980-04-28 | — | — | JP | disclosed |
| US-4196286-A | Process for the manufacture of basic oxazine dyestuffs | CIBA-GEIGY CORPORATION (US) | 1980-04-01 | — | — | US | disclosed |
| EP-0005451-A2 | Process for the manufacture of cationic oxazinic compounds, the oxazinic compounds and their application to the dyeing and printing of textile materials | CIBA-GEIGY AG (CH) | 1979-11-28 | — | — | EP | disclosed |
| US-4125717-A | NITROSATION OF AMINOPHENOL ETHERS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | disclosed |
| US-4125717-A | NITROSATION OF AMINOPHENOL ETHERS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | disclosed |
| US-4096157-A | PIGMENTS | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-06-20 | — | — | US | disclosed |
| US-3977826-A | HYDROGEN PEROXIDE, OXIDATION DYE COMPONENTS | CLAIROL INCORPORATED (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171765-A1 | Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents | WEE1, PCNA, ATIC | ALOX15 3816/4885TSHR 3550/4885ALDH1A1 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.